Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY® (approved as HANSIZHUANG in China) in European markets as First-Line Treatment for adult patients with Extensive-Stage Small Cell Lung Cancer ...Middle East

- HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC - HETRONIFLY® (serplulimab) is expected to become the first anti-PD-1 monoclonal antibody available in Europe for first-line treatment of ES-SCLC AHMEDABAD, India,...

Hence then, the article about henlius and intas receive positive chmp opinion for hetronifly approved as hansizhuang in china in european markets as first line treatment for adult patients with extensive stage small cell lung cancer was published today ( Saturday 21/09/2024 - 09:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY® (approved as HANSIZHUANG in China) in European markets as First-Line Treatment for adult patients with Extensive-Stage Small Cell Lung Cancer )

Also on site :

• The Nord Stream narrative explosion: Why you’ve only read half the story
• 2011 Concert Ended in Boos Just Weeks Before Iconic Singer's Death
• This 'Lightweight and Hydrating' Moisturizer Is a Frequent Repurchase for Ulta Shoppers—and It's Just $16